Frank Chia-Tang Hsu, DO
Cardiovascular Disease (Cardiology) · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hsu’s office to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$7,707
Pharmacies billed $7,707 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 112) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
103 generic and fewer than 11 brand-name prescriptions · $7,707 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 22 | $351 | $10 |
| Atorvastatin | 12 | $167 | $10 |
Year by year
| 2024 | 112 | 50 | 0% (0) | None | $7,707 |
| 2023 | 22 | 15 | 0% (0) | None | $2,157 |
| 2022 | 54 | 20 | 0% (0) | None | $5,858 |
| 2021 | 89 | 39 | 0% (0) | 17% | $5,671 |
| 2020 | 51 | 25 | 0% (0) | 22% | $3,798 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$474 in 2025
| 2025 | 4 | 5 | None | $474 |
| 2024 | 3 | 3 | None | $171 |
| 2023 | 3 | 7 | None | $442 |
| 2022 | 1 | 2 | None | $191 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Ensite | $279 | 2 payments
|
| Penumbra | Indigo System | $131 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $44 | 1 payment
|
| Boston Scientific | Watchman Flx | $20 | 1 payment
|
See all 5 published payments
| Edwards Lifesciences | Meals · 2025-06-20 | Sapien 3 Ultra Resilia | $44 |
| Penumbra | Meals · 2025-06-12 | Indigo System | $131 |
| Abbott Laboratories | Meals · 2025-05-29 | Mitraclip | $9 |
| Boston Scientific | Meals · 2025-04-17 | Watchman Flx | $20 |
| Abbott Laboratories | Education · 2025-02-19 | Ensite | $270 |
See earlier years (2024, 2023, 2022)
2024: $171
| Medtronic | Endurant Iis | $91 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $41 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $38 | 1 payment
|
2023: $442
| Medtronic | Corevalve Evolut R | $321 | 3 payments
|
| Cardiva Medical | Cardiva Vascade 6/7f Vcs | $97 | 3 payments
|
| Boston Scientific | Latitude Communicator Power Supply | $24 | 1 payment
|
2022: $191
| Novo Nordisk | Ozempic | $191 | 2 payments
|
Professional record
- NPI
- 1104454362
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 34 Mark West Springs Rd Fl 3, Santa Rosa, CA, 95403
- NPI first listed
- 2020-03-31
- NPI last updated
- 2026-07-28
- NPI record certified
- 2026-07-28
This is when the NPI record was last certified, not a medical board exam.